FDA Flags Vision Loss Risk on Wegovy, Zepbound

‼️ BREAKING: FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound. The FDA is requiring the makers of all GLP-1 medications to add a warning about the potential increased risk of NAION.
NAION is a rare condition caused by decreased blood flow to the front part of the optic nerve and can result in sudden decreased vision, including permanent vision loss

Leave a Reply